$LAZR
Luminar Technologies, Inc./DE

2019 Q1 Form 10-Q Financial Statement

#000156459019016032 Filed on May 06, 2019

View on sec.gov

Income Statement

Concept 2019 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$219.1K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $1.172M
YoY Change
Income Tax $278.3K
% Of Pretax Income 23.73%
Net Earnings $894.2K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.290M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $307.9K
Receivables
Other Receivables
Total Short-Term Assets $1.598M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $401.4M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.598M
Total Long-Term Assets $401.4M
Total Assets $403.0M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $628.2K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $956.4K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $956.4K
Total Long-Term Liabilities
Total Liabilities $14.96M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $872.2K
YoY Change
Common Stock $4.127M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.000M
YoY Change
Total Liabilities & Shareholders Equity $403.0M
YoY Change

Cashflow Statement

Concept 2019 Q1
OPERATING ACTIVITIES
Net Income $894.2K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $1.643M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$401.4M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 401.0M
YoY Change
NET CHANGE
Cash From Operating Activities 1.643M
Cash From Investing Activities -401.4M
Cash From Financing Activities 401.0M
Net Change In Cash 1.237M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $1.643M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001758057
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2019Q1 dei Trading Symbol
TradingSymbol
GMHIU
CY2019Q1 dei Entity Registrant Name
EntityRegistrantName
Gores Metropoulos, Inc.
CY2019Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q4 us-gaap Assets
Assets
489864
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
628169
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1289907
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52489
CY2018Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
437375
CY2019Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
307889
CY2019Q1 us-gaap Assets Current
AssetsCurrent
1597796
CY2018Q4 us-gaap Assets Current
AssetsCurrent
489864
CY2019Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
401390729
CY2019Q1 us-gaap Assets
Assets
402988525
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
335418
CY2019Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
50000
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1431
CY2019Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
278256
CY2018Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
150000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
956425
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
486849
CY2019Q1 gmhi Deferred Underwriting Compensation Liability Noncurrent
DeferredUnderwritingCompensationLiabilityNoncurrent
14000000
CY2019Q1 us-gaap Liabilities
Liabilities
14956425
CY2018Q4 us-gaap Liabilities
Liabilities
486849
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
383032090
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4126635
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
23922
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
872205
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21985
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
5000010
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
3015
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
402988525
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
489864
CY2019Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
38303209
CY2019Q1 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 gmhi Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
169059
CY2019Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
50000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-219059
CY2019Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1391505
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1172446
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
278256
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
894190
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
400000000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
10000000
CY2019Q1 gmhi Adjustments To Additional Paid In Capital Underwriters Discounts
AdjustmentsToAdditionalPaidInCapitalUnderwritersDiscounts
8000000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
865105
CY2019Q1 gmhi Adjustments To Additional Paid In Capital Stock Issued Deferred Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedDeferredIssuanceCosts
14000000
CY2019Q1 gmhi Reclassifications Of Permanent To Temporary Equity
ReclassificationsOfPermanentToTemporaryEquity
383032090
CY2019Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
6666666
CY2019Q1 gmhi Sale Of Warrants Price Per Warrant
SaleOfWarrantsPricePerWarrant
1.50
CY2019Q1 us-gaap Profit Loss
ProfitLoss
894190
CY2019Q1 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
48569
CY2019Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
307889
CY2019Q1 gmhi Increase Decrease In Deferred Offering Costs Associated With Proposed Public Offering
IncreaseDecreaseInDeferredOfferingCostsAssociatedWithProposedPublicOffering
437375
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
292751
CY2019Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-278256
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1643252
CY2019Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
400000000
CY2019Q1 us-gaap Payments To Acquire Trust Preferred Investments
PaymentsToAcquireTrustPreferredInvestments
1390729
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-401390729
CY2019Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
400000000
CY2019Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
10000000
CY2019Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
150000
CY2019Q1 gmhi Payment Of Underwriting Discounts And Commissions
PaymentOfUnderwritingDiscountsAndCommissions
8000000
CY2019Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
865105
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
400984895
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1237418
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
52489
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1289907
CY2019Q1 gmhi Deferred Underwriting Compensation
DeferredUnderwritingCompensation
14000000
CY2019Q1 gmhi Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
628169
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1431
CY2019Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Organization and Business Operations</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Organization and General</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gores Metropoulos,&#160;Inc. (the &#8220;Company&#8221;) was incorporated in Delaware on August 28, 2018. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more businesses (the &#8220;Business Combination&#8221;). The Company has neither engaged in any operations nor generated any operating revenue to date. The Company&#8217;s management has broad discretion with respect to the Business Combination. The Company&#8217;s Sponsor is Gores Metropoulos Sponsor, LLC, a Delaware limited liability company (the &#8220;Sponsor&#8221;). The Company has selected December&#160;31<sup style="font-size:85%; vertical-align:top">st</sup> as its fiscal&#160;year-end.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At March 31, 2019, the Company had not commenced any operations. All activity for the period from August 28, 2018 (inception) through March 31, 2019 relates to the Company&#8217;s formation and initial public offering (&#8220;Public Offering&#8221;) described below. The Company completed the Public Offering on February 5, 2019 (the &#8220;Public Offering Closing Date&#8221;). The Company will not generate any operating revenues until after the completion of its Business Combination, at the earliest. Subsequent to the Public Offering, the Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Public Offering and the sale of the Private Placement Warrants (as defined below) held in the Trust Account (as defined below).</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financing</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon the closing of the Public Offering and the sale of the Private Placement Warrants, an aggregate of $400,000,000 was placed in a Trust Account with Continental Stock Transfer&#160;&amp; Trust Company acting as trustee (the &#8220;Trust Account&#8221;).</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The Company intends to finance a Business Combination with the net proceeds from its $400,000,000 Public Offering and its sale of $10,000,000 of Private Placement Warrants.&nbsp;&nbsp;&nbsp;&nbsp; </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Trust Account</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Funds held in the Trust Account can be invested only in U.S. government treasury bills with a maturity of one hundred and eighty (180) days or less or in money market funds meeting certain conditions under Rule&#160;2a&#8209;7 under the Investment Company Act of 1940, as amended, that invest only in direct U.S. government obligations. As of March 31, 2019, the Trust Account consisted of cash and treasury bills.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to fund regulatory compliance requirements and other costs related thereto (a &#8220;Regulatory Withdrawal&#8221;), subject to an annual limit of $750,000, for a maximum 24 months and/or to pay franchise and income taxes, if any, none of the funds held in trust will be released until the earliest of: (i)&#160;the completion of the Business Combination; or (ii)&#160;the redemption of any public shares of common stock properly tendered in connection with a stockholder vote to amend the Company&#8217;s amended and restated certificate of incorporation to modify the substance or timing of the Company&#8217;s obligation to redeem 100% of such public shares of common stock if the Company does not complete the Business Combination within 24&#160;months from the closing of the Public Offering; or (iii)&#160;the redemption of 100% of the public shares of common stock if the Company is unable to complete a Business Combination within 24&#160;months from the closing of the Public Offering, subject to the requirements of law and stock exchange rules.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Business Combination</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds of the Public Offering are intended to be generally applied toward consummating a Business Combination. The Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (less any deferred underwriting commissions and taxes payable on interest income earned) at the time of the Company signing a definitive agreement in connection with the Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect a Business Combination.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company, after signing a definitive agreement for a Business Combination, will either (i)&#160;seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business&#160;days prior to the consummation of the Business Combination, including interest income but less taxes payable, or (ii)&#160;provide stockholders with the opportunity to sell their shares to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business&#160;days prior to the consummation of the Business Combination, including interest income but less taxes payable. The decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval, unless a vote is required by law or under NASDAQ rules. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Business Combination. In accordance with the Company&#8217;s charter, the Company will not redeem its public shares of common stock in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of its public shares of common stock and the related Business Combination, and instead may search for an alternate Business Combination.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the foregoing redemption provisions and as discussed in further detail in Note 2, the public shares of common stock will be recorded at the redemption amount and classified as temporary equity, in accordance with ASC 480, &#8220;<font style="font-style:italic;">Distinguishing Liabilities from Equity</font>&#8221; (&#8220;ASC 480&#8221;) in subsequent periods.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will have 24&#160;months from the Public Offering Closing Date to complete its Business Combination. If the Company does not complete a Business Combination within this period of time, it shall (i)&#160;cease all operations except for the purposes of winding up; (ii)&#160;as promptly as reasonably possible, but not more than ten business&#160;days thereafter, redeem the public shares of common stock for a per share pro rata portion of the Trust Account, including interest income, but less taxes payable (less up to $100,000 of such net interest income to pay dissolution expenses) and (iii)&#160;as promptly as possible following such redemption, dissolve and liquidate the balance of the Company&#8217;s net assets to its remaining stockholders, as part of its plan of dissolution and liquidation. The Sponsor and the Company&#8217;s officers and directors have entered into a letter agreement with the Company, pursuant to which they waived their rights to participate in any redemption with respect to their Founder Shares (as defined below); however, if the Sponsor or any of the Company&#8217;s officers, directors or affiliates acquire public shares of common stock, they will be entitled to a pro rata share of the Trust Account in the event the Company does not complete a Business Combination within the required time period.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial public offering price per Unit in the Public Offering.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Emerging Growth Company</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.</p>
CY2019Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution and the Trust Account, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.</p>
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2019Q1 gmhi Threshold Number Of Period To Provide Opportunity To Shareholders To Sell Their Shares Prior To Consummation Of Business Combination
ThresholdNumberOfPeriodToProvideOpportunityToShareholdersToSellTheirSharesPriorToConsummationOfBusinessCombination
P2D
CY2019Q1 gmhi Dissolution Expenses Maximum Allowed
DissolutionExpensesMaximumAllowed
100000
CY2019Q1 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2019Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2019Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2019Q1 gmhi Redemption Percentage To Allow Release Of Funds Held In Trust
RedemptionPercentageToAllowReleaseOfFundsHeldInTrust
1.00
CY2019Q1 gmhi Redemption Rights Or Liquidating Distributions With Respect To Warrants
RedemptionRightsOrLiquidatingDistributionsWithRespectToWarrants
0
CY2019Q1 gmhi Working Capital
WorkingCapital
641371
CY2018Q4 gmhi Working Capital
WorkingCapital
3015
CY2019Q1 gmhi Percentage Of Deferred Underwriting Discount
PercentageOfDeferredUnderwritingDiscount
0.0350
CY2019Q1 gmhi Deferred Underwriting Discount If Business Combination Not Completed
DeferredUnderwritingDiscountIfBusinessCombinationNotCompleted
0
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2466
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q1 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
220000000
CY2019Q1 gmhi Number Of Votes For Each Share
NumberOfVotesForEachShare
1
CY2019Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
400000000
CY2019Q1 gmhi Period Of Maturity Of Trust Account Investments Maximum
PeriodOfMaturityOfTrustAccountInvestmentsMaximum
P180D
CY2019Q1 gmhi Regulatory Withdrawal Of Interest From Trust Account Annual Limit
RegulatoryWithdrawalOfInterestFromTrustAccountAnnualLimit
750000
CY2019Q1 gmhi Regulatory Withdrawal Of Interest From Trust Account Maximum Period
RegulatoryWithdrawalOfInterestFromTrustAccountMaximumPeriod
P24M
CY2019Q1 gmhi Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
1.00
CY2019Q1 gmhi Threshold Number Of Period To Seek Shareholders Approval Prior To Consummation Of Business Combination To Redeem Their Shares
ThresholdNumberOfPeriodToSeekShareholdersApprovalPriorToConsummationOfBusinessCombinationToRedeemTheirShares
P2D

Files In Submission

Name View Source Status
0001564590-19-016032-index-headers.html Edgar Link pending
0001564590-19-016032-index.html Edgar Link pending
0001564590-19-016032.txt Edgar Link pending
0001564590-19-016032-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gmhi-10q_20190331.htm Edgar Link pending
gmhi-20190331.xml Edgar Link completed
gmhi-20190331.xsd Edgar Link pending
gmhi-20190331_cal.xml Edgar Link unprocessable
gmhi-20190331_def.xml Edgar Link unprocessable
gmhi-20190331_lab.xml Edgar Link unprocessable
gmhi-20190331_pre.xml Edgar Link unprocessable
gmhi-ex311_29.htm Edgar Link pending
gmhi-ex312_28.htm Edgar Link pending
gmhi-ex321_26.htm Edgar Link pending
gmhi-ex322_27.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending